Earnings Ahead

VKTX - VIKING THERAPEUTICS INC.

14.835 -3.305 -18.22

VIKING THERAPEUTICS INC.

VIKING THERAPEUTICS INC.

About

Profile


Headquarters

California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

VKTX

Shares surged more than 33% following the drug developers announcement that its experimental obesity treatment, VK2735, will be moved to a phase 3 clinical trial. The company also said that an oral version of the drug will begin phase 2 trials in the fourth quarter.


 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Viking Therapeutics GAAP EPS of -$0.25 beats by $0.01
  • Viking Therapeutics Q4 2023 Earnings Preview
  • Eli Lilly hurts NASH drug developers after mid-stage win for obesity therapy
  • Viking Therapeutics gains amid takeover speculation
  • Barron’s cites cancer and weight loss plays for biotech M&A
  • J.P. Morgan event in spotlight as biotech M&A, obesity frenzy, AI pick up
  • Viking Therapeutics rises on Roche acquiring peer Carmot
  • Pfizer hits new 52-week low after weight loss setback
  • Viking Therapeutics stock climbs as liver drug shows efficacy among key patient subgroups
  • Viking Therapeutics GAAP EPS of -$0.23 misses by $0.01
  • Viking Therapeutics Q3 2023 Earnings Preview
  • Biggest stock movers today: Morgan Stanley, Spirit AeroSystems, United Airlines and more
  • Viking Therapeutics rises after Phase 1 data for weight loss therapy
  • Drugmakers still chasing potentially lucrative NASH market, despite setbacks
  • Watch weight loss stocks after cardiovascular data for Wegovy
  • Nearly half of U.S. adults want weight-loss drugs – KFF poll
  • Viking Therapeutics files for mixed shelf offering
  • Viking Therapeutics GAAP EPS of -$0.19 in-line
  • Viking Therapeutics Q2 2023 Earnings Preview
  • Viking Therapeutics gains as Street defends after selloff

Earnings History

Date EPS / Forecast Revenue / Forecast
February 9, 2022 -0.16 / -0.188 - / -
November 3, 2021 -0.17 / -0.21 - / -
July 28, 2021 -0.2 / -0.1962 - / -
April 28, 2021 -0.19 / -0.1736 - / -
February 17, 2021 -0.15 / -0.1524 - / -
October 28, 2020 -0.13 / -0.152 - / -
April 30, 2020 -0.13 / -0.12 - / -
February 26, 2020 -0.1 / -0.13 - / -
Date Price Open High Low Vol Change
Jul 24 50.41 50.84
52.18
50.27
3.6M -2.19%
Jul 23 51.54 51.5
52.85
51
2.1M -0.33%
Jul 22 51.71 50.81
51.96
48.78
2.3M 1.59%
Jul 19 50.9 49.94
52.34
49.75
1.9M 1.60%
Jul 18 50.1 51.08
51.68
48.53
2.6M 0.52%
 
Jul 17 49.84 53.69
53.78
48.26
6.4M -12.56%
Jul 16 57 59.94
60.25
56.75
2.0M -4.01%
Jul 15 59.38 57.63
60
56.66
2.1M 3.85%
Jul 12 57.18 58.82
59.79
57.13
2.1M -2.47%
Jul 11 58.63 56.44
60.23
56.42
3.8M 1.10%
Jul 10 57.99 54.29
58.71
54.17
4.0M 7.09%
Jul 9 54.15 51.4
54.93
51.04
2.4M 6.16%
Jul 8 51.01 51.75
53.17
50.17
1.8M -0.51%
Jul 5 51.27 50.91
52.3
50.25
1.5M 1.59%
Jul 3 50.47 51.89
52.6
49.85
1.6M -2.08%
Jul 2 51.54 54.01
55.29
51.5
3.1M -6.83%
Jul 1 55.32 53.38
58.26
52.5
4.2M 4.36%
Jun 28 53.01 51.3
54.8
51.05
16.2M 4.41%
Jun 27 50.77 50.83
51.48
47.9
4.8M 7.13%
Jun 26 47.39 47.45
47.98
46.11
2.8M -0.86%
Jun 25 47.8 52.29
52.6
47.54
4.8M -8.29%
Jun 24 52.12 52.42
54.42
51.45
3.0M -1.18%
Jun 21 52.74 50.7
53.96
50.08
7.2M 4.58%
Jun 20 50.43 50.64
51.9
49.56
2.9M -0.41%
Jun 18 50.64 52
52.93
50.3
3.1M -2.65%
Jun 17 52.02 51.61
53.96
50.2
3.2M 0%
Jun 14 52.02 51.08
52.85
48.2
5.1M -0.15%
Jun 13 52.1 52.08
53.13
51.03
2.6M -0.69%
Jun 12 52.46 54.18
54.9
51.52
2.9M -0.51%
Jun 11 52.73 55.4
55.76
52.5
3.3M -6.47%
Jun 10 56.38 55
57.31
54.84
1.9M 0.70%
Jun 7 55.99 54.51
56.96
53.76
2.6M 1.78%
Jun 6 55.01 58.31
58.43
54.53
3.9M -6.57%
Jun 5 58.88 57
60.15
55.8
3.9M 4.71%
Jun 4 56.23 65
65.42
52.31
11.4M -9.7%
Jun 3 62.27 62.27
65.15
60.7
2.4M 0.02%
May 31 62.26 62.22
63.5
61.51
2.2M 0.78%
May 30 61.78 63.89
64.88
60.68
2.4M -3.18%
May 29 63.81 64
64.79
63.03
1.6M -2.37%
May 28 65.36 63.46
65.9
62.33
2.3M 4.16%
May 24 62.75 62.2
64.24
61.43
2.1M 1.92%
May 23 61.57 63.85
64.98
61.09
3.3M -2.29%
May 22 63.01 64.63
64.63
62.25
3.1M -1.9%
May 21 64.23 67.42
67.6
63.66
3.5M -4.86%
May 20 67.51 66.85
68.53
66.18
2.5M 0.76%
May 17 67 69.99
71.09
66.68
4.1M -2.98%
May 16 69.06 76.26
76.89
68.4
7.5M -11.47%
May 15 78.01 73.97
79.88
72.69
4.2M 7.60%
May 14 72.5 72.88
74.21
71.55
1.5M 0.21%
May 13 72.35 74.39
74.95
70.43
2.6M -1.75%
May 10 73.64 80.12
80.19
73.21
4.0M -8.18%
May 9 80.2 80.49
81.81
78.61
2.4M 0.36%
May 8 79.91 78.13
79.97
76.75
1.8M 0.38%
May 7 79.61 78.27
81.86
76.51
3.7M 1.79%
May 6 78.21 76.97
79.88
73.69
3.2M 1.61%
May 3 76.97 74.49
77.68
72.88
3.8M 1.60%
May 2 75.76 78.13
78.13
73.41
2.1M -0.88%
May 1 76.43 78.31
80.38
75.66
4.1M -3.96%
Apr 30 79.58 75
80.25
74.8
3.8M 5.52%
Apr 29 75.42 74.54
76.44
73.5
2.8M 0%